drugset / Trial / NCT05053126

Study Evaluating Abuse Potential of Lyrica® in Healthy Non-Drug Dependent Recreational Opioid Users

NCT05053126

Phase 4 Completed 60 enrolled Viatris Specialty LLC
RandomizedCrossoverTriple-blindOther

Summary

This is a Phase 4 clinical study in healthy non-drug dependent recreational opioid users to assess the abuse potential of Lyrica when taken alone or in combination with oxycodone.

Timeline

Start
2021-07-27
Primary completion
2022-04-01
Completion
2022-04-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Oxycodone Other / unclassified 20 mg Oral
Subject Pregabalin Small molecule 300 mg Oral
Subject Pregabalin Small molecule 450 mg Oral

Indications